StreetInsider.com News Articles

Leerink Starts Parabilis Medicines (PBLS) at Outperform

Mon, 06 Jul 2026 06:20:35 -0400

(Updated - July 6, 2026 6:20 AM EDT)

Leerink analyst Andrew Berens initiates coverage on Parabilis Medicines (NASDAQ: PBLS) with a Outperform rating and a price target of $40.00.

The analyst comments "We are initiating coverage of Parabilis Medicines (PBLS) with an OP rating and a $40 PT. The company's lead asset is zolucatetide, a first-in-class β-catenin inhibitor that blocks the β-catenin/TCF interaction, the most downstream node of the Wnt pathway. Zolucatetide is being developed in desmoid tumors, familial adenomatous polyposis (FAP), adamantinomatous craniopharyngioma (ACP), hepatocellular carcinoma (HCC), colorectal cancer (CRC), and other Wnt/ β-catenin-driven tumors. Historically, the Wnt pathway has been

Leerink Starts Parabilis Medicines (PBLS) at Outperform

Mon, 06 Jul 2026 06:20:35 -0400

(Updated - July 6, 2026 6:20 AM EDT)

Leerink analyst Andrew Berens initiates coverage on Parabilis Medicines (NASDAQ: PBLS) with a Outperform rating and a price target of $40.00.

BofA Securities Starts Parabilis Medicines (PBLS) at Buy

Mon, 06 Jul 2026 06:11:10 -0400

BofA Securities analyst Tazeen Ahmad initiates coverage on Parabilis Medicines (NASDAQ: PBLS) with a Buy rating and a price target of $45.00.

The analyst comments "We initiate coverage of Parabilis Medicines (PBLS) with a Buy and $45 PO. PBLS is a clinical-stage biotech developing therapeutics for previously ‘undruggable’ targets. Underpinned by its novel AI-driven Helicon platform, PBLS is focused on lead asset zolucatetide for non-cancerous desmoid tumors. The company also has an early-stage pipeline including a collaboration with REGN to expand novel antibody-helicon conjugates into new therapeutic areas beyond oncology. Early clinical data for zolu in desmoid tumors demonstrate compelling efficacy

BofA Securities Starts Parabilis Medicines (PBLS) at Buy

Mon, 06 Jul 2026 06:11:10 -0400

BofA Securities analyst Tazeen Ahmad initiates coverage on Parabilis Medicines (NASDAQ: PBLS) with a Buy rating and a price target of $45.00.

Evercore ISI Starts Parabilis Medicines (PBLS) at Outperform

Mon, 06 Jul 2026 06:04:24 -0400

Evercore ISI analyst Umer Raffat initiates coverage on Parabilis Medicines (NASDAQ: PBLS) with a Outperform rating.

For an analyst ratings summary and ratings history on Parabilis Medicines click here. For more ratings news on Parabilis Medicines click here.

Shares of Parabilis Medicines closed at $29.58 yesterday.

Guggenheim Starts Parabilis Medicines (PBLS) at Buy

Mon, 06 Jul 2026 02:39:15 -0400

Guggenheim analyst Michael Schmidt initiates coverage on Parabilis Medicines (NASDAQ: PBLS) with a Buy rating and a price target of $40.00.

The analyst comments: “Under leadership of its experienced executive team, PBLS has developed the “Helicon platform”, a peptide-based drug discovery engine producing cell-penetrant helical peptides that can engage historically "undruggable" targets. We believe the platform serves as a differentiated product engine, which PBLS leverages to build a pipeline of wholly owned product candidates addressing difficult, but mechanistically validated cancer targets, and industry R&D collaborations (e.g., with REGN). Lead product candidate zolucatetide, a first-in-class, direct β-catenin inhibitor, is a “pipeline in

Guggenheim Starts Parabilis Medicines (PBLS) at Buy

Mon, 06 Jul 2026 02:39:15 -0400

Guggenheim analyst Michael Schmidt initiates coverage on Parabilis Medicines (NASDAQ: PBLS) with a Buy rating and a price target of $40.00.

Form 4 Parabilis Medicines, For: Jun 11 Filed by: Soleus Private Equity Fund III, L.P.

Mon, 29 Jun 2026 10:41:00 -0400

si-local-file:///var/storage/secattach/20260629/26703787.html

Form 3 Parabilis Medicines, For: Jun 09 Filed by: Soleus Private Equity Fund III, L.P.

Mon, 29 Jun 2026 10:38:00 -0400

si-local-file:///var/storage/secattach/20260629/26703764.html

Form SCHEDULE 13D Parabilis Medicines, Filed by: RA CAPITAL MANAGEMENT, L.P.

Thu, 18 Jun 2026 16:10:00 -0400

si-local-file:///var/storage/secattach/20260618/26666062.html

Form 4 Parabilis Medicines, For: Jun 12 Filed by: SEBULSKY ALAN

Tue, 16 Jun 2026 18:19:00 -0400

si-local-file:///var/storage/secattach/20260616/26655555.html

Form 4 Parabilis Medicines, For: Jun 11 Filed by: Shah Rajeev M.

Mon, 15 Jun 2026 18:58:00 -0400

si-local-file:///var/storage/secattach/20260615/26648967.html

Form 4 Parabilis Medicines, For: Jun 09 Filed by: FITZGERALD EDWARD M

Mon, 15 Jun 2026 17:35:00 -0400

si-local-file:///var/storage/secattach/20260615/26648764.html

Form 4 Parabilis Medicines, For: Jun 11 Filed by: SEBULSKY ALAN

Mon, 15 Jun 2026 17:28:00 -0400

si-local-file:///var/storage/secattach/20260615/26648725.html

Form 4 Parabilis Medicines, For: Jun 11 Filed by: Borisy Alexis

Mon, 15 Jun 2026 17:18:00 -0400

si-local-file:///var/storage/secattach/20260615/26648618.html

Form 4 Parabilis Medicines, For: Jun 11 Filed by: DEERFIELD MANAGEMENT COMPANY, L.P.

Thu, 11 Jun 2026 20:08:00 -0400

si-local-file:///var/storage/secattach/20260611/26637225.html

Form 4 Parabilis Medicines, For: Jun 09 Filed by: Shah Rajeev M.

Thu, 11 Jun 2026 18:36:00 -0400

si-local-file:///var/storage/secattach/20260611/26637094.html

Form 4 Parabilis Medicines, For: Jun 09 Filed by: Weber Barbara

Thu, 11 Jun 2026 16:53:00 -0400

si-local-file:///var/storage/secattach/20260611/26636548.html

Form 4 Parabilis Medicines, For: Jun 09 Filed by: Borisy Alexis

Thu, 11 Jun 2026 16:53:00 -0400

si-local-file:///var/storage/secattach/20260611/26636556.html

Form 4 Parabilis Medicines, For: Jun 09 Filed by: Yeshwant Krishna

Thu, 11 Jun 2026 16:52:00 -0400

si-local-file:///var/storage/secattach/20260611/26636547.html

Form 4 Parabilis Medicines, For: Jun 09 Filed by: Simson Jake

Thu, 11 Jun 2026 16:48:00 -0400

si-local-file:///var/storage/secattach/20260611/26636492.html

Form 4 Parabilis Medicines, For: Jun 09 Filed by: FITZGERALD EDWARD M

Thu, 11 Jun 2026 16:48:00 -0400

si-local-file:///var/storage/secattach/20260611/26636495.html

Form 4 Parabilis Medicines, For: Jun 09 Filed by: Klausner Richard

Thu, 11 Jun 2026 16:43:00 -0400

si-local-file:///var/storage/secattach/20260611/26636438.html

Form 4 Parabilis Medicines, For: Jun 09 Filed by: SEBULSKY ALAN

Thu, 11 Jun 2026 16:41:00 -0400

si-local-file:///var/storage/secattach/20260611/26636414.html

Form 8-K Parabilis Medicines, For: Jun 09

Thu, 11 Jun 2026 16:13:00 -0400

si-local-file:///var/storage/secattach/20260611/26635776.html